U.S. Tech Hardware Stock News

Some investors may be wondering if Broadcom's share price still offers value after a large multi year run, or if most of the upside is already reflected in the stock. The shares closed at US$320.33, with a 3.7% decline over the last 7 days and a 7.9% decline over the last 30 days. Over the last 1 year the return sits at 45.3%, and the 5 year return is around 7x. Recent news coverage has focused on Broadcom's role as a major semiconductor and infrastructure software player and how that...

RPC (RES) has just posted its FY 2025 third quarter scorecard, reporting revenue of $447.1 million and basic EPS of $0.06. This puts fresh numbers on the table after a run of mixed earnings over the past year. The company’s revenue has moved from $364.2 million in FY 2024 Q2 to $337.7 million in Q3 and $335.4 million in Q4, then to $332.9 million, $420.8 million and now $447.1 million through FY 2025. Over the same stretch, quarterly EPS shifted from $0.15 to $0.09, $0.06, $0.06, $0.05 and...

Spire Inc. reported past first‑quarter 2026 results with sales of US$762.2 million and net income of US$95 million, alongside announcing the redemption of all 5.90% Series A preferred shares and affirming its quarterly common dividend of US$0.825 per share. Beyond the headline earnings growth, Spire’s decision to retire its higher-cost preferred stock while pursuing an US$11.2 billion long-term capital plan underpins a clearer, streamlined capital structure and reinforces management’s focus...

Waters Corporation (NYSE:WAT) has completed its acquisition of Wyatt Technology as part of a broader shift in its business strategy. The company has also announced a planned merger with BD Biosciences, signaling a push deeper into large molecule applications. These moves are expected to reshape Waters' role in the biotech and life sciences tools space, with implications for its future operations. Waters, trading at $378.95, is responding to a period of mixed share performance with an active...

At its Perform 2026 user conference held in late January, Dynatrace unveiled Dynatrace Intelligence, fusing deterministic and agentic AI, alongside expanded multi-cloud integrations and next-generation real user monitoring capabilities. An interesting aspect of these launches is Dynatrace’s push to position its platform as a control plane for AI in production, aiming to automate complex IT and business operations. We’ll now examine how Dynatrace Intelligence’s focus on agentic AI and...

If you are wondering whether Newell Brands' current share price reflects its true worth, you are not alone. This article walks through what the latest data says about value. The stock most recently closed at US$4.40, with returns of 0.9% over 7 days and 18.3% over both the last 30 days and year to date, against a longer term record that includes a 52.0% decline over 1 year, 67.4% over 3 years and 79.4% over 5 years. Those mixed returns sit against a backdrop of ongoing attention on Newell...

Twist Bioscience (NasdaqGS:TWST) reported its twelfth consecutive quarter of revenue growth. The company raised its full year outlook, citing momentum in AI enabled DNA synthesis and wider use of its platform. Management also reiterated a focus on progressing toward profitability alongside scaling the business. Twist Bioscience, a provider of synthetic DNA and related tools, operates at the intersection of biotechnology and AI driven research. Its platform supports customers in areas such...

GE Vernova (NYSE:GEV) has entered a wide-ranging alliance with Xcel Energy covering gas and wind turbine deployments, grid projects, and joint R&D in areas such as artificial intelligence. The company launched its GridBeats APS grid modernization platform, aimed at improving efficiency, resilience, and capacity across power networks. GE Vernova also completed the full acquisition of Prolec GE, integrating additional grid equipment capabilities into its portfolio. For you as an investor...

In late January 2026, Glaukos Corporation received FDA approval for an NDA labeling supplement that permits repeat administration of its long-duration iDose TR glaucoma implant, supported by clinical data showing safe and well-tolerated second treatments over 12 months. This decision effectively positions iDose TR as a potentially longer-term, repeatable treatment option aimed at reducing non-compliance and side effects linked to traditional eye-drop therapies for glaucoma. Next, we will...

Why Lionsgate Studios Stock Is Drawing Attention Now Lionsgate Studios (LION) has caught investor attention after recent trading left the share price at US$8.98, with returns ranging from a 3.4% decline over the month to a 33.2% gain in the past 3 months. See our latest analysis for Lionsgate Studios. Recent trading has been choppy, with a 1-day share price return of 2.7% decline and a 7-day share price return of 6.2% decline. However, the 90-day share price return of 33.2% suggests momentum...

East West Bancorp (NasdaqGS:EWBC) announced a 33% increase in its quarterly dividend. The higher dividend follows the company’s latest annual and quarterly results, which management described as strong. The move signals an increased cash return to shareholders through the regular dividend. East West Bancorp is a commercially focused bank with a footprint that connects U.S. and Asia linked clients, serving businesses and individuals across a range of lending and deposit services. For...

Amphenol (NYSE:APH) has agreed to acquire CommScope's Connectivity and Cable Solutions division, expanding its fiber optic interconnect offering. The move broadens Amphenol's presence in connectivity for AI data centers and communications infrastructure. The acquisition highlights management's focus on building out capabilities in high demand data and AI related applications. For investors watching NYSE:APH, this deal comes with the stock recently trading at $147.06 and showing very large 3...

CorVel (CRVL) has just wrapped up Q3 2026 with its recent numbers anchored by the latest reported quarter, where revenue in Q2 2026 was US$239.6 million and basic EPS came in at US$0.54. This feeds into trailing 12 month EPS of US$2.05 and net income of US$105.3 million. Over the recent reporting periods, the company has seen revenue move from US$224.4 million in Q2 2025 to US$239.6 million in Q2 2026, with basic EPS stepping from US$0.46 to US$0.54 over the same quarters. This sets up a...

Mesa Laboratories (MLAB) just posted its latest numbers with recent quarterly revenue of about US$60.7 million and basic EPS of US$0.45, while the trailing twelve months show revenue of roughly US$245.3 million and a small net loss of US$1.6 million. Over the past few quarters, the company has seen revenue move between US$57.8 million and US$62.8 million, with EPS ranging from a loss of US$1.31 per share to a profit of US$0.87 per share. This sets up a mixed picture on profitability, even as...

Corning (NYSE:GLW) has signed a multiyear agreement to supply Meta Platforms with advanced optical fiber and cable for AI data centers. The company is investing in expanded manufacturing capacity to support this contract. Corning is also participating in the US federal Project Vault initiative for critical minerals stockpiling. Corning, trading at $112.79, has seen very strong recent share price performance, with the stock up 24.4% over the past month and 120.9% over the past year. Returns...

CVS Health pharmacies are set to leave the Horizon NJ Health Medicaid network, affecting close to 1 million New Jersey Medicaid customers. The move follows a dispute over pharmacy reimbursement terms between CVS Health and Horizon NJ Health. Once the change takes effect, Horizon NJ Health Medicaid members will no longer be able to use CVS pharmacies under their current plan. For investors tracking NYSE:CVS, this network exit comes alongside a share price of $76.83 and a mixed set of recent...

Capital Southwest (CSWC) just posted Q3 2026 results with total revenue of US$61.4 million and basic EPS of US$0.57, setting the tone for another data rich update on its earnings power. The company has seen quarterly revenue move from US$51.9 million in Q3 2025 to US$61.4 million in Q3 2026, while basic EPS shifted from US$0.34 to US$0.57 over the same period. This gives investors a clear sense of how the top and bottom lines have trended into this quarter. With a trailing 12 month net profit...

CLEAR Secure recently reported that its biometric identity verification business has delivered 23.2% annual revenue growth over the last two years, while maintaining disciplined cost controls that produced a trailing 12‑month operating margin of 19.2%. This combination of rapid top-line expansion and efficient use of fixed costs highlights how the company is scaling its airport and venue network without proportionately increasing expenses. Next, we will examine how Clear Secure's strong cost...

Coca-Cola (NYSE:KO) acquired Zico Coconut Water after a creative pitch from serial entrepreneur Jesse Itzler. The deal offers a behind the scenes look at how less traditional proposals can influence Coca-Cola's portfolio decisions. The Zico acquisition adds a coconut water brand to Coca-Cola's wider beverage lineup. Coca-Cola, traded under NYSE:KO, is best known for its core soft drink brands, but its portfolio also includes a range of non carbonated beverages. The Zico story shows how the...

Speculative surge puts TechCreate Group (TCGL) in the spotlight TechCreate Group (TCGL) has been thrust into the market spotlight after a very large short term share price spike, including volatility halts, largely linked to speculative trading and momentum driven sentiment. See our latest analysis for TechCreate Group. With TechCreate Group’s share price now at $172.84 after a 1 day share price return of around 100% and a very large 30 day gain, the move caps a powerful short term run that...

Why Brunswick’s latest earnings matter for investors Brunswick (BC) is back in the spotlight after fourth quarter results showed a return to profit compared with a loss a year earlier, alongside an updated share buyback tally and a shift in analyst sentiment. See our latest analysis for Brunswick. Brunswick’s recent earnings return to profit and confirmation of sizeable buybacks appear to have supported a strong run in the shares, with a 30 day share price return of 13.06% and a 1 year total...

Event context and recent share performance Figure Technology Solutions (FIGR) has drawn fresh attention after recent trading left the stock down about 15% over the past day and roughly 29% over the past week, despite modest gains over the past month and past 3 months. See our latest analysis for Figure Technology Solutions. The sharp 1-day and 7-day share price returns, down 14.85% and 29.05% respectively, contrast with a 15.14% 3-month share price return and a positive year to date share...

In recent days, Amazon has moved to cut about 16,000 corporate roles, confirmed plans for a further 2,200 job reductions in Washington state starting April 28, and continued to highlight artificial intelligence as a core focus across AWS, logistics, and broader operations ahead of its February 5 earnings release. What stands out is how Amazon is pairing aggressive cost-cutting with deeper AI ties, including preliminary talks to invest up to US$50.00 billion in OpenAI and a US$38.00 billion...

Vera Therapeutics recently appointed Matt Skelton as Chief Commercial Officer, effective January 28, 2026, elevating him from his prior role as Executive Vice President, Commercial to lead preparations around the potential launch of its lead drug candidate, atacicept, for IgA nephropathy. His background in building commercial organizations and guiding multiple drug launches at Seagen, Amgen, and Eli Lilly highlights Vera’s emphasis on experienced leadership as it moves toward possible...